总统's Advisory Council

Harvey Arbit在制药行业拥有超过40年的监管事务领域的经验, 临床研究, 质量控制, and product development. Dr. Arbit is the founder of, and consulting partner for, Arbit咨询, 有限责任公司, providing regulatory strategy and support for industry, 学术界, and investigator-initiated sponsored 临床研究.

Nancy Barbour is senior vice president of Drug Product Science & Technology at Bristol-Myers Squibb (BMS). 在这个角色中, 她负责整个小分子管道的全球产品和工艺开发, 生物化合物, 和设备. Dr. 在获得ACPHS的药剂学学士学位和堪萨斯大学的药物化学博士学位后，Barbour于1991年加入BMS.

Rebecca Blanchard is the Vice 总统 of Experimental Medicine at CRISPR Therapeutics. Prior to joining CRISPR, Dr. Blanchard是默克公司人类遗传学和药物基因组学部门的临床药物基因组学负责人. Her career in 学术界 and in industry has spanned preclinical, 平移, and clinical development across multiple therapeutic areas.

Robert Blum co-founded Buffalo 临床研究 Center, 有限责任公司 (BCRC) in 2001. BCRC是一个最先进的I期研究机构，协助制药公司进行早期药物开发. BCRC engages in a wide range of research activities including “first-time-in-man” safety, tolerability and pharmacokinetic/ pharmacodynamic studies, bioavailability/ bioequivalence, 药物相互作用, gender-and food-effect studies.

Mac Bonafede是 Vice 总统 of 研究 Consulting at Veradigm, an Allscripts Company. He has extensive 经验 in the areas of healthcare research, education, and consulting. Before joining Truven Health, Dr. Bonafede served on the faculty at Albany College of Pharmacy and 健康科学, where he taught courses covering research and statistical methods, total quality management, and evidence-based medicine.

David Carpenter is Executive Director, 临床研究, at Evecxia Therapeutics, a privately funded clinical stage pharmaceutical company based in 研究 Triangle Park, NC. Evecxia的使命是开发和商业化的新产品，以治疗常见的糖尿病患者, 残疾和昂贵的神经精神疾病，目前的治疗方法往往是次优的，以帮助那些患有精神疾病的人更充实, more meaningful lives. Dr. Carpenter previously held senior leadership drug development roles at GSK, 赛诺菲安万特, Dart Neuroscience and Roivant Sciences.

Christopher Conway is 总统 at Curia Global (previously Albany Molecular 研究, 公司.). Prior to joining Curia, Mr. Conway held sales, marketing, and leadership positions at Johnson & Johnson, where he completed J&J’s 领导 Development Program and received both Johnson & Johnson’s Global Standards of 领导 and Global Innovation Awards.

As the Vice 总统, 市场准入, 分布 and Patient Access Services at 公司yte Corporation, Joseph Cordaro负责领导商业职能和负责付款人国民账户的现场团队, 战略客户, 分布, Patient Access Services, and Channel Marketing for current and future products. Prior to joining 公司yte, Dr. Cordaro held leadership positions with AstraZeneca, Roche Pharmaceuticals, and Novartis Pharmaceuticals Corporation.

Chris Dadas is the Vice 总统, Global Head Medical Affairs Vice 总统, Global Head Medical Affairs at Eiger BioPharmaceuticals, 公司. His work fully integrates medical communications from many internal and external stakeholders, driving corporate research strategy and scientific direction. Prior to his current position, Dr. Dadas served in a variety of roles at AbbieVie and Allergan, 公司.

Dr. Diliberto has more than 44 years of 学术, pharmaceutical industry, and government R&D体验. His past positions have included serving as Professor & Chair of the Department of Pharmaceutical Sciences at Campbell University College of Pharmacy & Burroughs Wellcome公司药理学部门分子和细胞药理学部门的健康科学和小组组长.

Chris Di Lascia is the 总统, CEO, and co-founder of Transition Patient Services (TPS). 此前，他曾任职于Aventis Pharmaceuticals，担任Lovenox的全球营销总监. 他在制药行业的职业生涯始于Eli Lilly and Company的医院销售代表，之后加入Schering-Plough担任管理式医疗和政府事务经理.

Clayton Edwards是AllianceRx Walgreens Prime的首席运营官，他领导着该组织近80%的员工的企业运营. Operations include specialty and home delivery operations​; business innovation and advanced therapies; facilities management, logistics and engineering​; service delivery and ops excellence​; plus, operations planning and execution.

Seve Falati是一名注册专利律师和位于奥尔巴尼的Falati知识产权法的管理合伙人 & Management Consultancy firm, where he leads a group of seven intellectual property law attorneys. His clients include U.S. and foreign based entities with interests in new and emerging 技术. In addition to his law degree, 他拥有药理学博士学位，并在哈佛医学院/贝斯以色列女执事医疗中心完成了为期三年的博士后研究.

吉娜C. 古尔德, 博士学位, has been a museum enthusiast since childhood and is happy in her role as 总统 of “miSci,” Schenectady’s Museum of Innovation and Science. Her love of the environment, 地球的历史, and the objects that testify to that history, has shaped her career. After receiving a BS in Zoology from SUNY Oswego, 古尔德加入和平队，担任巴拉圭国家自然历史博物馆哺乳动物学馆长. 之后, 古尔德 worked for Ralph Appelbaum Associates, 直到她被美国自然历史博物馆授予哥伦比亚大学Lamont-Doherty地球天文台地球与环境科学博士项目的奖学金. Since then, 古尔德 has pursued a career in developing science exhibitions for museums nationwide. 康涅狄格大学环境科学与工程中心副教授, 古尔德喜欢把她对科学的热爱和她对讲述这些故事的热情通过身临其境的动手STEAM展览和编程为所有年龄和兴趣的人.

After earning both her 药学博士 (PharmD) and MS in Pharmaceutical Sciences from ACPHS, Jaclyn于2012年开始在Regeneron Pharmaceuticals工作，目前担任副董事, CMC Project Management. Her previous positions at Regeneron have included Senior Manufacturing Process & Technology Associate and Associate Manager, Technology Transfer.

弗兰克·格罗索是 Executive Vice 总统 Corporate Development at ActualMeds Corporation. He has 35 years of Long Term Care Pharmacy 经验, including serving as Vice 总统 of Pharmacy Services for Genesis Healthcare, a long term care provider. 他在Genesis的职责包括监督411个护理中心和辅助生活社区的运营和合同药房服务. 

Marylee Grosso is Managing Partner, 医疗咨询, 有限责任公司, 一个独立的咨询公司，解决面临的挑战后急症护理提供者, 供应商, and professional organizations in a rapidly changing regulatory and reimbursement environment. Prior to her current role, she served as Corporate Senior Director of Clinical Operations for Genesis Healthcare, 监督全国500多个中心的护理和医务部的临床药学实践标准. 

Stephen Hulse is the Senior Director, Healthcare Market at Genentech, one of the world's leading biotechnology companies. He has 25+ years of 经验 in the pharmaceutical industry, including extensive management expertise at the district, 区域, 国家层面. He is an 经验d marketer of several major branded franchises, including international strategic development, and domestic business development initiatives.

David Kvancz is Senior Vice 总统, Strategic Client Relationships at Visante, a healthcare consulting firm with a focus on medication use and system optimization. Before joining Visante, Mr. Kvancz曾担任Kaiser Permanente的国家药房项目和服务副总裁, prior to that 经验, he was the Chief Pharmacy Officer for the Cleveland Clinic Health System.

Shawn Leland ’08 is the Founder and CEO of Elevation Oncology, which was formed in 2019 and went public in 2021. Shawn为制药/生物技术行业带来了超过十年的医疗事务和业务开发经验. Shawn参与了Eli Lilly的全球交易，总计超过4.5亿美元的预付款和里程碑付款, ARIAD Pharmaceuticals, Argos Therapeutics and Verastem Oncology. 他拥有ACPHS的药学博士学位，并通过罗格斯大学(Rutgers)完成了Bristol Myers Squibb的行业奖学金.

Stephen McCormack is passionate about the development of medical products, 技术, and services that address unmet medical needs. He currently serves as Managing General Partner, Exela 有限责任公司. His scientific contributions and patents include delivery of drugs to the eye, medical devices for the treatment of tinnitus, and diagnostic tests for cervical cancer.

阿德卡·麦金托什医学博士, is a board certified Radiologist with Radiology Associates of North Texas.  He completed his medical training at Baylor College of Medicine in Houston, and then spent several years in residency programs, first at the University of Michigan, and then at the University of Minnesota.  The focus of his residency was general surgery and diagnostic radiology.

He completed a fellowship at Children’s Hospital of Philadelphia. There, his sub-specialties were pediatric radiology and pediatric interventional radiology.

南希·菲利普斯, ’74 BS Pharm is the founder and CEO of Phillips Gilmore Oncology Communications, a 27-year old Philadelphia-based global medical communications company, specializing in oncology, 血液学, 和生物技术. Upon graduating from Albany College of Pharmacy, Nancy became one of the originators of the profession of oncology pharmacy, working for a decade at the SUNY Upstate Medical Center in Syracuse.

Ernesto Samuel has more than 35 years of global 经验 in cosmetic, 放射性药物的, and pharmaceutical industries in the USA, 加拿大, 欧洲和亚洲. Mr. Samuel previously held senior leadership positions at Syncor, 公司; Pharmalogic, 有限责任公司 and IBA Molecular, 公司, spanning areas of operations, 质量保证, and regulatory affairs. 目前,先生. Samuel is the CEO of Pharmaceutic Labs, a 503B Outsourcing Facility in Albany, NY manufacturing sterile and non-sterile medications and CEO of Biomed Innova, FDA注册的实验室位于奥尔巴尼医学中心(AMC)校园，是AMC生物医学加速和商业化中心(BACC)的一部分。. Biomed Innova specializes in new drug formulations, 分析测试, clinical studies and quality and regulatory consulting.

Darren Triller is Director of Strategic Initiatives at the Anticoagulation Forum, 北美最大的多学科抗凝专家成员组织(www.acforum.org). 在这个角色中, 他领导了一系列由fda资助的工作，以确定和推进抗凝管理作为国家护理模式. He also led the recent creation and approval of a novel, ASHP-approved PGY2 pharmacy specialty residency in Thrombosis and Hemostasis Management. He has contributed to the development of national quality measures, developed an app for the periprocedural management of anticoagulants, and has published extensively on drug safety topics.

Mr. Ullmann brings leadership, 经验, 以及在医疗保健和健康行业的私营和公共部门拥有独特背景的执行经理的技能. He has developed more than 30 start-up companies, and for 16 years served as the Founder, 主席, 总统, 总部位于纽约的上市健康管理公司(Wellcare)的首席执行官，该公司开发和管理了六个hmo.